EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19
Clinical trial NCT05059106 · UNKNOWN
Trial details
- NCT number
- NCT05059106
- Sponsor
- Federal University of Espirito Santo
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2022-06-01
- Enrollment
- 29637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.